Global medical aesthetics company Vime announced that it held the international academic event "JULIA SUMMIT GLOBAL 2025" from November 3rd to 5th, targeting medical professionals from approximately 30 countries around the world. The event, which lasted two nights and three days, was attended by approximately 300 doctors from various regions, including Asia, Central and South America, and the Middle East, including its European distribution partner, Fillmed.
The symposium, held at Yongsan Dragon City in Seoul, featured 11 presentations under the theme "The Juvelook Revolution: Science, Practice, Future." The program included a video presentation on the scientific background and mechanism of action of Juvelook, clinical cases from Korea and Europe, and in-depth techniques for safe and effective treatments. The symposium also included opportunities to share domestic treatment trends, such as acne scar treatment, with international medical professionals and to introduce the new Juvelook i and G products.
The published clinical data contributed to a broader understanding of Juvelook's efficacy and potential for expanded use among medical professionals. The safety was also emphasized, sharing the experiences of domestic medical professionals who have used the product for extended periods.
Vime hosted this large-scale event in Korea and offered a variety of programs. Experience-focused programs included a "Doctor to Doctor" seminar, where medical professionals shared their surgical expertise, a visit to the "Juve Look Book House" pop-up store in Seongsu-dong, and a tour of the company's second factory in Daejeon.
A BIM representative stated that this event was a celebration of Juvelook's achievements in overseas markets, and that the overwhelming number of applications confirmed the high level of interest. They also expressed their commitment to continuously enhancing their global competitiveness by strengthening their brand value based on scientific evidence.
- See more related articles
You must be logged in to post a comment.